4//SEC Filing
Andrews Kurt J. 4
Accession 0001209191-18-023850
CIK 0001178879other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 5:39 PM ET
Size
9.4 KB
Accession
0001209191-18-023850
Insider Transaction Report
Form 4
Andrews Kurt J.
SVP, Human Resources
Transactions
- Sale
Common Stock
2018-04-02$14.27/sh−5,000$71,343→ 40,469 total - Exercise/Conversion
Stock Options (right to buy)
2018-04-02−5,000→ 60,000 totalExercise: $6.13Exp: 2026-02-01→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2018-04-02$6.13/sh+5,000$30,650→ 45,469 total
Footnotes (3)
- [F1]The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017.
- [F2]This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.00 to $14.76. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]These options vest and become exercisable in a series of installments. The first installment, which consisted of 25% of the total aggregate number of options granted, vested on February 1, 2017. The remaining options began to vest and become exercisable in a series of thirty-five successive equal monthly installments on March 1, 2017, with the final installment vesting on February 1, 2020.
Documents
Issuer
AMICUS THERAPEUTICS INC
CIK 0001178879
Entity typeother
Related Parties
1- filerCIK 0001636133
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 5:39 PM ET
- Size
- 9.4 KB